Tag: #M&A

On February 13, 2026, Ampersand Capital Partners completed the acquisition of Purna Pharmaceuticals, a Belgium-based CDMO specializing in liquid and... Read more

Eli Lilly has officially announced the acquisition of Orna Therapeutics, a biotech startup specializing in re-engineering immune cells directly inside... Read more

Kuva Labs, a specialist in cancer imaging, has entered into a binding agreement to acquire Lisata Therapeutics, a biotech firm... Read more

GSK has entered into a definitive agreement to acquire California-based RAPT Therapeutics for $58.00 per share, representing a total equity... Read more

Merger & Acquisition Update Verana Health, a real-world data (RWD) analytics firm, has announced the acquisition of oncology specialist COTA... Read more

Biopharmaceutical giant AbbVie has announced a definitive agreement to acquire a device manufacturing facility in Tempe, Arizona, along with associated... Read more

The global pharmaceutical market is abuzz with reports that Merck & Co. (MSD) is in active negotiations to acquire Revolution... Read more

U.S. biotech giant Amgen has agreed to acquire Oxford-based Dark Blue Therapeutics in a deal valued at up to $840... Read more

On January 8, 2026, Day One Biopharmaceuticals announced the formal completion of its acquisition of Mersana Therapeutics following the satisfaction... Read more